Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New York · 2025 Regular Session · Bill

A 11256: Requires health plan coverage to include certain generic drugs and biosimilars

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

A 11256 is a bill introduced in the New York House on May 4, 2026. According to its official title, it concerns: Requires health plan coverage to include certain generic drugs and biosimilars. Primary sponsor: Josh Jensen (Republican/Conservative/Independence). Most recent recorded action (May 4, 2026): REFERRED TO INSURANCE.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Requires health plan coverage to include generic drugs and biosimilars where the wholesale acquisition cost of such generic drugs or biosimilars is lower than the brand drug's wholesale acquisition cost.

Sponsors

Sponsors by party (alphabetical): Republican/Conservative/Independence 1

NameRolePartyChamberDistrict
Josh JensenPrimary sponsorRepublican/Conservative/IndependenceHouse134

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. REFERRED TO INSURANCE

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source